What Is Difference Between Insulin and Glucagon? A Product Comparison
Abstract: Insulin and glucagon are critical peptide hormones with opposing metabolic roles. Insulin (e.g., Novo Nordisk’s Novolog) lowers blood glucose via cellular uptake, while glucagon (e.g., Eli Lilly’s Baqsimi) raises it via glycogenolysis. Market trends show a $12B insulin sector (2023) vs. a growing glucagon niche (CAGR 8.5%). Product comparison highlights insulin’s superior stability (2-8°C) vs. glucagon’s lyophilized fragility. Key parameters: insulin analogs (e.g., Lispro) offer faster onset (15 min) than human insulin (30 min). Glucagon’s emergency use dominates, while insulin spans diabetes management. Industry data (IQVIA, 2024) indicate 90% of peptide products require GMP certification. Selection tips prioritize purity (>98% HPLC) and cold-chain logistics.